Renal Cell Cancer Update

Dr Jesús Berdeja from the Sarah Cannon Research Institute in Nashville, Tennessee, discusses recent advances and future directions in the use of CAR T-cell therapy for the management of multiple myeloma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCARTMM21).

Dr Kristen Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, discusses key presentations on gastrointestinal cancers from the 2021 ASCO Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOGI21).

Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses key presentations on breast cancer from the 2021 ASCO Annual meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOBreast).

Dr Jaffer Ajani from MD Anderson Cancer Center in Houston, Texas discusses the latest clinical data on immune checkpoint inhibitors and other novel agents in the management of gastroesophageal cancers. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayGEJ21).

Dr Arjun Balar from the NYU Perlmutter Cancer Center in New York discusses key presentations on genitourinary cancers from the 2021 ASCO Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASCOGU21).

Dr Guillermo Garcia-Manero from the MD Anderson Cancer Center discusses clinical data with new and emerging approaches for the management of myelodysplastic syndromes. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayMDS21).

Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2LocalizedBC21).

Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEarlyBCGenomicAssays21).

Dr Morie Gertz from the Mayo Clinic in Rochester, Minnesota, discusses the diagnosis and management of amyloid light chain amyloidosis. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAmyloidosis21).

Mitesh Borad from the Mayo Clinic Comprehensive Cancer Center in Scottsdale, Arizona, discusses the biology of cholangiocarcinoma and clinical data with new and emerging targeted approaches for patients with this disease. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayCholangiocarcinoma21).

Dr Roy Herbst from the Yale Cancer Center discusses the clinical data on and optimal use of adjuvant osimertinib for patients with resected non-small cell lung cancer and an EGFR mutation. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEGFRNSCLC21).

Dr Laurie Sehn from the BC Cancer Center for Lymphoid Cancer in Vancouver, Canada, discusses the latest clinical research findings on non-Hodgkin and Hodgkin lymphomas from the 2020 ASH Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASHLymphomaCLL21/Issue2).

Dr Natalie Callander from the University of Wisconsin Carbone Cancer Center discusses key presentations on multiple myeloma, Waldenström macroglobulinemia and amyloidosis from the 2020 ASH Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASHMM21).

Dr Roberto Iacovelli from the Fondazione Policlinico Universitario A Gemelli in Rome discusses the spectrum and management of side effects with hormonal therapies in prostate cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayProstateHoromonalTherapy21).

Dr Harry Erba from Duke University in Durham, North Carolina, discusses key presentations on acute myeloid leukemia and myelodysplastic syndromes from the 2020 AS Annual Meeting. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayPostASHAMLMDS21).

Dr Manmeet Ahluwalia from the Miami Cancer Institute of Baptist Health South Florida discusses recently published and emerging research on the management of CNS metastases in patients with non-small cell lung cancer. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCNSMetsNSCLC21).

Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York discusses recently published and emerging research on the treatment of diffuse large B-cell lymphoma. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayDLBCL21).

Dr Andrew Wei from the Alfred Hospital and Monash University in Melbourne, Australia, discusses recently published and emerging research on the treatment of acute myeloid leukemia not eligible for intensive induction therapy. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLIntensiveTx21).

Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid discusses the latest clinical data on and optimal integration of PARP inhibitors in ovarian cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayFrontLineCLL21).

Professor Solange Peters from Lausanne University Hospital in Switzerland discusses existing and emerging biomarkers of response to cancer immunotherapy. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayImmunotherapies21).